Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,265 across all filing types
Latest filing 2021-08-09 AGM Information
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the summary of proceedings of the 42nd Annual General Meeting (AGM) of AstraZeneca Pharma India Ltd. It lists the business transacted at the AGM, including adoption of financial statements, appointment and re-appointment of directors and auditors, and ratification of auditor remuneration. It also mentions that voting results will be announced later. The document is short (3486 characters) and serves as a summary or announcement of the AGM proceedings rather than the full AGM materials or minutes. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries thereof.
2021-08-09 English
We would wish to inform that at the Meeting of the Board of Directors of the Company held today i.e., on August 9, 2021, the Board have inter-alia declared an Interim Dividend of Rs. 2 ....
Notice of Dividend Amount Classification · 100% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) dated August 9, 2021. It announces the declaration of an interim dividend of Rs. 2 per equity share by the Board of Directors, specifies the record date for entitlement, and the payment date. The document is short (1675 characters) and is an announcement of a dividend declaration, not a full financial report or detailed dividend report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-08-09 English
Dividend
Notice of Dividend Amount Classification · 100% confidence The document is a letter addressed to stock exchanges announcing the declaration of an interim dividend by the Board of Directors. It specifies the dividend amount, record date, and payment date. The content is a formal announcement of dividend details rather than a full financial report or detailed analysis. The document length is short (1675 characters), and it clearly states the dividend declaration and related dates. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-08-09 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) dated August 9, 2021. It announces the declaration of an interim dividend of Rs. 2 per equity share by the Board of Directors, specifies the record date for entitlement (August 20, 2021), and the payment date (on or before September 7, 2021). The content is a formal announcement of dividend declaration and payment details, without any financial statements or detailed report data. The document length is short (1675 characters), and it is clearly an announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-08-09 English
AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2021, inter alia, has declared Interim Dividend of Rs. 2 per equity ....
Interim / Quarterly Report Classification · 100% confidence The document is dated August 9, 2021, and is addressed to stock exchanges regarding the outcome of a board meeting. It includes approval of unaudited financial results for the quarter ended June 30, 2021, along with a limited review report from statutory auditors. The document also declares an interim dividend and sets a record date for dividend entitlement. The presence of detailed unaudited financial results, notes on accounting standards, and an auditor's limited review report indicates this is a quarterly financial report. The document is over 13,000 characters, so it is not a mere announcement but contains substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2021-08-09 English
The Board of Directors of the Company at their meeting held today i.e, August 9, 2021, has inter-alia: 1. Approved the Unaudited Financial Results of the Company for the quarter ....
Interim / Quarterly Report Classification · 100% confidence The document is dated August 9, 2021, and contains unaudited financial results for the quarter ended June 30, 2021. It includes detailed financial data, notes on accounting standards, segment information, and management commentary on COVID-19 impact and legal matters. The document also contains an Independent Auditors' Review Report by Price Waterhouse & Co Chartered Accountants LLP, which reviews the unaudited quarterly financial results. The presence of detailed financial statements and auditor's review for a quarter strongly indicates this is an Interim / Quarterly Report. The document is over 13,000 characters, so it is not a brief announcement or a report publication notice. Therefore, the classification is Interim / Quarterly Report (IR). Q1 2022
2021-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.